-1 2- f% Orricia, Record FD-302 (Rev. 5-8-10) lof 2 nm FEDERAL BUREAU OF INVESTIGATION Date of entry 09/05/2019 DR. KARI SCHLESSINGER, date of birth (DOB) QM, was interviewed at 1 Saint Andrews Plaza, New York, NY, 10007 (US Attorney's Office, Southern District of New York). Present at the interview was Office of the Inspector General (OIG) Special Agent (SA) Re. Assistant U.S. Attorney (AUSA) ),,. enc Fs: sa BJ. stter being advised of the identity of the interviewing Agents and the nature of the interview, DR. SCHLESSINGER provided the following statement: DR. SCHLESSINGER has a PhD Psychology DR. SCHLESSINGER interned at in Metropolitan Detention Center in 2004. DR. SCHLESSINGER started working at Metropolitan Detention Center in 2005. DR. SCHLESSINGER transferred to Metropolitan Correctional Center in 2009. DR. SCHLESSINGER conducts Forensic Psychological Evaluations of inmates for the Bureau of Prisons. DR. SCHLESSINGER conducted an intake interview of EPSTEIN on July 8. 2019. During the interview, EPSTEIN denied any mental health history, suicide history, and substance abuse history. EPSTEIN stated, although he was in the "shoe", he was doing fine. (A copy of DR. SCHLESSINGER's July, 8, 2019, intake screening of EPSTEIN will be maintained in a 1A ssociated with this serial). On August 9, 2019 at approximately 1:00pm, DR. SCHLESSINGER, acting for DR. MILLER, was present during a meeting regarding EPSTIEN. During the meeting, EPSTEIN's attorney was opposed EPSTEIN having a cell mate. During the meeting, ADAM JOHNSON and DR. SCHLESSINGER explained to EPSTEIN's attorney, that because EPSTEIN was in the "shoe", and he was a sex offender, Investigationon 08/30/2019 at NewYork, New York, United States (In Person) File? QOA-NY¥~-3151227 Date drafted 09/05/2019 ye This document contains neither recommendations nor conclusions of the FBI. It is the property of the FBI and is loaned to your agency; it and its contents are not to be distributed outside your agency. EFTA00075355

--=PAGE_BREAK=--

FD-302a (Rev. 5-8-10) 9OA-NY-3151227 Continuation of FD-302 of (U) Interview of DR. KARI SCHLESSINGER (On 08/30/2019 Page 2 OF 2 EPSTEIN needed a cell mate. EPSTIEN's cell mate being released was never brought up that August 9, 2019 meeting. EFTA00075356